Bjarke Ebert

5.6k total citations
125 papers, 4.5k citations indexed

About

Bjarke Ebert is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Bjarke Ebert has authored 125 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Cellular and Molecular Neuroscience, 76 papers in Molecular Biology and 21 papers in Organic Chemistry. Recurrent topics in Bjarke Ebert's work include Neuroscience and Neuropharmacology Research (83 papers), Receptor Mechanisms and Signaling (31 papers) and Chemical Synthesis and Analysis (20 papers). Bjarke Ebert is often cited by papers focused on Neuroscience and Neuropharmacology Research (83 papers), Receptor Mechanisms and Signaling (31 papers) and Chemical Synthesis and Analysis (20 papers). Bjarke Ebert collaborates with scholars based in Denmark, United States and United Kingdom. Bjarke Ebert's co-authors include Povl Krogsgaard‐Larsen, Keith A. Wafford, Signe ı́ Stórustovu, Steen Andersen, Bente Frølund, Ulf Madsen, Christian Thorkildsen, Connie Sánchez, Martin Mortensen and Finn Molke Borgbjerg and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Neurology.

In The Last Decade

Bjarke Ebert

124 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bjarke Ebert Denmark 37 2.7k 1.9k 773 707 473 125 4.5k
Lee E. Schechter United States 42 2.6k 1.0× 2.3k 1.2× 456 0.6× 672 1.0× 849 1.8× 95 5.3k
Hans Rommelspacher Germany 43 2.5k 0.9× 2.3k 1.2× 407 0.5× 744 1.1× 635 1.3× 178 5.4k
Mark D. Tricklebank United Kingdom 46 4.3k 1.6× 2.4k 1.3× 1.5k 1.9× 646 0.9× 374 0.8× 125 6.3k
Graham J. Riley United Kingdom 31 2.3k 0.9× 1.8k 1.0× 458 0.6× 779 1.1× 797 1.7× 70 4.1k
Edilio Borroni Switzerland 35 1.9k 0.7× 1.5k 0.8× 806 1.0× 469 0.7× 270 0.6× 91 4.3k
Silvio Caccia Italy 44 2.4k 0.9× 1.5k 0.8× 432 0.6× 1.0k 1.4× 485 1.0× 194 5.8k
Enrico Sanna Italy 38 2.4k 0.9× 1.3k 0.7× 581 0.8× 244 0.3× 402 0.8× 122 4.6k
Luca Ferraro Italy 48 3.4k 1.3× 2.4k 1.2× 1.1k 1.4× 1.5k 2.1× 177 0.4× 207 7.1k
Aaron Janowsky United States 43 3.5k 1.3× 2.6k 1.3× 426 0.6× 649 0.9× 430 0.9× 129 5.5k
Claus Bræstrup Denmark 32 4.1k 1.5× 2.3k 1.2× 977 1.3× 404 0.6× 570 1.2× 56 5.3k

Countries citing papers authored by Bjarke Ebert

Since Specialization
Citations

This map shows the geographic impact of Bjarke Ebert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bjarke Ebert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bjarke Ebert more than expected).

Fields of papers citing papers by Bjarke Ebert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bjarke Ebert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bjarke Ebert. The network helps show where Bjarke Ebert may publish in the future.

Co-authorship network of co-authors of Bjarke Ebert

This figure shows the co-authorship network connecting the top 25 collaborators of Bjarke Ebert. A scholar is included among the top collaborators of Bjarke Ebert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bjarke Ebert. Bjarke Ebert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baune, Bernhard T., Ioana Florea, Bjarke Ebert, et al.. (2021). Patient Expectations and Experiences of Antidepressant Therapy for Major Depressive Disorder: A Qualitative Study. Neuropsychiatric Disease and Treatment. Volume 17. 2995–3006. 11 indexed citations
2.
Ebert, Bjarke, et al.. (2017). An ethnographic study of the effects of cognitive symptoms in patients with major depressive disorder: the IMPACT study. BMC Psychiatry. 17(1). 370–370. 13 indexed citations
3.
Betry, Cécile, Ouissame Mnie‐Filali, Adeline Etiévant, et al.. (2012). Synergistic antidepressant-like action of gaboxadol and escitalopram. European Neuropsychopharmacology. 22(10). 751–760. 11 indexed citations
4.
Wafford, Keith A. & Bjarke Ebert. (2008). Emerging anti-insomnia drugs: tackling sleeplessness and the quality of wake time. Nature Reviews Drug Discovery. 7(6). 530–540. 78 indexed citations
5.
Ebert, Bjarke, et al.. (2004). Escitalopram versus citalopram: the surprising role of the R-enantiomer. Psychopharmacology. 174(2). 163–76. 208 indexed citations
6.
Vestergaard, Henrik Tang, Stine B. Vogensen, Ulf Madsen, & Bjarke Ebert. (2004). Analogues of homoibotenic acid show potent and selective activity following sensitisation by quisqualic acid. European Journal of Pharmacology. 488(1-3). 101–109. 4 indexed citations
7.
Sánchez, Connie, et al.. (2003). Rotarod studies in the rat of the GABAA receptor agonist gaboxadol: lack of ethanol potentiation and benzodiazepine cross-tolerance. European Journal of Pharmacology. 482(1-3). 215–222. 39 indexed citations
8.
Ebert, Bjarke, et al.. (2003). Extrasynaptic GABAA channels activated by THIP are modulated by diazepam in CA1 pyramidal neurons in the rat brain hippocampal slice. Molecular and Cellular Neuroscience. 24(1). 250–257. 22 indexed citations
9.
Mortensen, Martin, et al.. (2002). Activity of novel 4-PIOL analogues at human α1β2γ2S GABAA receptors—correlation with hydrophobicity. European Journal of Pharmacology. 451(2). 125–132. 14 indexed citations
10.
Ebert, Bjarke, et al.. (1997). Differences in Agonist/Antagonist Binding Affinity and Receptor Transduction Using Recombinant Human γ-Aminobutyric Acid Type A Receptors. Molecular Pharmacology. 52(6). 1150–1156. 127 indexed citations
11.
Johansen, Tommy N., Karla Frydenvang, Bjarke Ebert, Ulf Madsen, & Povl Krogsgaard‐Larsen. (1997). Excitatory amino acid receptor antagonists: Resolution, absolute stereochemistry, and pharmacology of (S)- and (R)-2-amino-2-(5-tert-butyl-3-hydroxyisoxazol-4-yl)acetic acid (ATAA). Chirality. 9(5-6). 529–536. 5 indexed citations
12.
Madsen, Ulf, Karla Frydenvang, Bjarke Ebert, et al.. (1996). N-Methyl-d-aspartic Acid Receptor Agonists:  Resolution, Absolute Stereochemistry, and Pharmacology of the Enantiomers of 2-Amino-2-(3-hydroxy-5-methyl-4-isoxazolyl)acetic Acid. Journal of Medicinal Chemistry. 39(1). 183–190. 20 indexed citations
13.
Andersen, Steen, et al.. (1996). The opioid ketobemidone has a NMDA blocking effect. Pain. 67(2). 369–374. 21 indexed citations
14.
Bräuner‐Osborne, Hans, Bjarke Ebert, Mark R. Brann, Erik Falch, & Povl Krogsgaard‐Larsen. (1996). Functional partial agonism at cloned human muscarinic acetylcholine receptors. European Journal of Pharmacology. 313(1-2). 145–150. 20 indexed citations
15.
Bräuner‐Osborne, Hans, Bjarke Ebert, Mark R. Brann, E. FALCH, & Povl Krogsgaard‐Larsen. (1995). Annulated Heterocyclic Bioisosteres of Norarecoline. Synthesis and Molecular Pharmacology at Five Recombinant Human Muscarinic Acetylcholine Receptors. Journal of Medicinal Chemistry. 38(12). 2188–2195. 13 indexed citations
16.
Bischoff, François, Tommy N. Johansen, Bjarke Ebert, Povl Krogsgaard‐Larsen, & Ulf Madsen. (1995). Excitatory amino acid receptor ligands: Asymmetric synthesis, absolute stereochemistry and pharmacology of (R)- and (S)-homoibotenic acid. Bioorganic & Medicinal Chemistry. 3(5). 553–558. 14 indexed citations
17.
Ebert, Bjarke, Steen Andersen, & Povl Krogsgaard‐Larsen. (1995). Ketobemidone, methadone and pethidine are non-competitive N-methyl-d-aspartate (NMDA) antagonists in the rat cortex and spinal cord. Neuroscience Letters. 187(3). 165–168. 201 indexed citations
18.
Christensen, Inge Thøger, Bjarke Ebert, Ulf Madsen, et al.. (1992). Excitatory amino acid receptor ligands. Synthesis and biological activity of 3-isoxazolol amino acids structurally related to homoibotenic acid. Journal of Medicinal Chemistry. 35(19). 3512–3519. 28 indexed citations
19.
Ebert, Bjarke, Erik H.F. Wong, & Povl Krogsgaard‐Larsen. (1991). Identification of a novel NMDA receptor in rat cerebellum. European Journal of Pharmacology Molecular Pharmacology. 208(1). 49–52. 66 indexed citations
20.
Madsen, Ulf, John W. Ferkany, Bruce Edward Jones, et al.. (1990). NMDA receptor agonists derived from ibotenic acid. Preparation, neuroexcitation and neurotoxicity. European Journal of Pharmacology Molecular Pharmacology. 189(6). 381–391. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lee E. Schechter Breakdown of academic impact, for papers by Hans Rommelspacher Breakdown of academic impact, for papers by Mark D. Tricklebank Breakdown of academic impact, for papers by Graham J. Riley Breakdown of academic impact, for papers by Edilio Borroni Breakdown of academic impact, for papers by Silvio Caccia Breakdown of academic impact, for papers by Enrico Sanna Breakdown of academic impact, for papers by Luca Ferraro Breakdown of academic impact, for papers by Aaron Janowsky Breakdown of academic impact, for papers by Claus Bræstrup
Rankless by CCL
2026